Jefferies John 4

What Happened
John Jefferies, Chief Medical Officer of DAXOR CORP (DXR), reported acquiring a total of 5,941 shares on March 20, 2026. The Form 4 lists two transactions coded as "P" (purchase) at $0.00 per share: 2,285 shares that vested immediately and 3,656 shares that are subject to vesting in 2029. No cash was reported as paid in these entries.

Key Details

• Transaction date: March 20, 2026 (reported on Form 4 filed March 24, 2026).
• Reported price: $0.00 per share for both entries (total reported cash outlay $0).
• Share breakdown: 2,285 shares vested on March 20, 2026; 3,656 shares vest on March 20, 2029.
• Shares owned after transaction: Not disclosed on this Form 4.
• Footnotes: F1 notes the 3,656 shares vest on 3/20/2029; F2 notes the 2,285 shares vested on 3/20/2026.
• Filing timeliness: Form 4 was filed March 24, 2026 for a 3/20/2026 transaction (filed within the typical two-business-day window).

Context
The $0.00 price and the vesting schedule indicate these entries are award/compensation-related stock grants rather than a cash market purchase. Immediate vesting (2,285 shares) increases Jefferies' current holdings; the remaining 3,656 shares are time‑restricted until 2029. These filings are routine reporting of insider compensation and do not, by themselves, indicate a market view.